NAG (N-Acetyl-β-D-Glucosaminidase) Test
🧪 NAG (N-Acetyl-β-D-Glucosaminidase) Test: Complete Review
Early Marker of Proximal Tubular Injury · Colorimetric Assay · Reference Range · Clinical Interpretation (NAG test)
N-Acetyl-β-D-Glucosaminidase (NAG) is a lysosomal enzyme highly concentrated in the proximal renal tubules.
Because it is barely present in blood and is excreted exclusively through urine, urinary NAG levels correlate strongly with the degree of tubular cell injury.
Even when serum creatinine (Cr) and eGFR remain normal, NAG may rise early—making it one of the most sensitive markers for early tubular damage.
1. Purpose of the Test
① Early detection of proximal tubular injury
NAG becomes elevated before creatinine or eGFR changes, making it valuable for early screening.
② Monitoring drug-induced nephrotoxicity
Common nephrotoxic agents:
- Aminoglycosides
- Cisplatin
- NSAIDs
- Cyclosporine / Tacrolimus
NAG is often the earliest biomarker to rise after exposure.
③ Early diabetic nephropathy evaluation
NAG may increase before microalbuminuria, reflecting early tubular involvement.
④ Monitoring renal allograft function
Used as an adjunct marker to detect tubular injury in acute rejection.
⑤ Screening in AKI and CKD
Useful for:
- Ischemic AKI
- Sepsis-related kidney injury
- Tubulointerstitial nephritis
- CKD progression monitoring
2. Test Method: Colorimetric Assay
Urinary NAG is typically measured using a colorimetric (colorimetry-based) method.
🔬 Principle
A synthetic substrate (p-nitrophenyl-N-acetyl-β-D-glucosaminide) is hydrolyzed by NAG, releasing p-nitrophenol, a yellow chromogen.
The absorbance is measured via spectrophotometry → proportional to NAG activity.
⚠ Important considerations
- Use fresh first-morning urine when possible.
- Hematuria and UTI may increase NAG.
- Enzyme activity varies with pH and storage time → analyze immediately or refrigerate.
- Many labs report NAG/Creatinine ratio for normalization.
3. Reference Range
Ranges vary by manufacturer; a typical example:
- NAG/Cr ratio: 1.0 – 7.0 U/g creatinine
Always interpret based on your lab’s specific reference interval.
4. Clinical Significance
NAG elevation reflects tubular cell injury, inflammation, or lysosomal leakage.
Because it rises early, it is considered one of the most sensitive markers of proximal tubular dysfunction.
5. Conditions Associated with Increased NAG (↑)
1) Drug-induced nephrotoxicity
- Aminoglycosides
- Cisplatin
- NSAIDs
- Cyclosporine, Tacrolimus
One of the earliest markers after toxic exposure.
2) Diabetic nephropathy (early stage)
Sensitive to early tubular involvement—may precede microalbuminuria.
3) Acute Kidney Injury (AKI)
- Ischemic AKI (shock, hypotension)
- Sepsis-induced AKI
- Rhabdomyolysis
- Glomerulonephritis / nephritic syndrome
4) Chronic Kidney Disease (CKD)
Sustained elevation indicates chronic tubular-interstitial damage.
5) Kidney transplant rejection
Often rises earlier than serum creatinine.
6) Other causes
- UTI
- Hematuria
- Hypertensive nephropathy
- Heavy proteinuria
6. Decreased NAG (↓)
Less clinically relevant. Possible scenarios:
- Severe renal failure with very low urine output
- Protein malnutrition
- Medications inhibiting enzyme activity
7. Interpretation Tips
- Consider specimen quality (pH, storage).
- Do not interpret NAG alone—use with Cr, BUN, eGFR, urinalysis, proteinuria.
- NAG/Cr ratio is often more reliable than absolute NAG.
- Review medication history for nephrotoxic agents.
- Watch for false increases with UTI or hematuria.
Lysozyme (Muramidase) Test (26) – MedLab Insight
8. Summary Table
| Category | Content |
|---|---|
| Test | NAG (N-Acetyl-β-D-Glucosaminidase) |
| Purpose | Early marker of proximal tubular injury |
| Method | Colorimetric (p-nitrophenol detection) |
| Reference Range | 1.0–7.0 U/g Cr (lab-dependent) |
| Increased in | Nephrotoxic drugs, AKI, CKD, diabetic nephropathy, transplant rejection |
| Decreased in | Limited significance |
| Key Point | Rises before serum creatinine → early damage detection |
9. References
- Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th ed.
- Henry’s Clinical Diagnosis and Management by Laboratory Methods, 24th ed.
- Kidney International: Urinary N-acetyl-β-D-glucosaminidase as a marker of tubular damage
- Clinical Chemistry and Laboratory Medicine: Biomarkers of acute kidney injury (NAG, NGAL, KIM-1)
- Toxicology Letters: Early detection of nephrotoxicity using urinary NAG